Otsuka Pharmaceutical Co., Ltd.

208 articles about Otsuka Pharmaceutical Co., Ltd.

• Otsuka Pharmaceutical Co., Ltd. Announces FDA Clearance For The RAPIRUN(R) H. pylori Antibody Detection Kit

  11/28/2006

• New Data On Otsuka Pharmaceutical Co., Ltd.'s Investigational Product For Hyponatremia Presented At American Heart Association Annual Meeting

  11/14/2006

• Otsuka Pharmaceutical Co., Ltd. To Release Oral Vasopressin V2-receptor Antagonist Drug

  10/12/2006

• Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd. Launch New Rapidly Disintegrating Oral Antipsychotic Medication ABILIFY(R) DISCMELT(TM) (aripiprazole)

  8/17/2006

• Otsuka Pharmaceutical Co., Ltd. To Ship Antipsychotic Agent

  6/8/2006

• Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd. Release: Six-Month Study Evaluated Effectiveness Of Aripiprazole And Standard Of Care In Management Of Community-Treated Patients With Schizophrenia

  5/25/2006

• Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd. Release: ABILIFY(R) (Aripiprazole) Demonstrated Efficacy As Maintenance Therapy In Adults With Bipolar I Disorder Following Treatment For A Recent Manic Or Mixed Episode

  5/16/2006

• Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd. Announce Availability Of 2 mg ABILIFY(R) (aripiprazole) Tablet And Nonrefrigerated Oral Solution

  2/7/2006